Table 1.
Demographic, clinical and laboratory characteristics of telmisartan and amlodipine groups at baseline
| Telmisartan group (n=39) | Amlodipine group (n=38) | Control group (n=33) | P | |
|---|---|---|---|---|
| Age, years | 48±11 | 48±9 | 49±5 | 0.735 |
| Female, n,% | 17 (43) | 16 (42) | 12 (36) | 0.810 |
| Height, cm | 170±9 | 170±9 | 165±5 | 0.078 |
| Weight, kg | 75±12 | 78±11 | 72±5 | 0.089 |
| BMI, kg/m2 | 25.9±2.4 | 26.8±2.1 | 26.4±1.5 | 0.175 |
| Glucose, mg/dL | 95±7 | 93±6 | 92±4 | 0.182 |
| HDL, mg/dL | 46±11 | 49±18 | 40±8 | 0.163 |
| LDL, mg/dL | 145±41 | 130±42 | 134±25 | 0.227 |
| Triglyceride, mg/dL | 126±32 | 131±34 | 118±27 | 0.342 |
| Creatinine, mg/dL | 0.7±0.1 | 0.7±0.1 | 0.7±0.1 | 0.333 |
| Hemoglobin, mg/dL | 14.4±1.3 | 15.0±1.4 | 15.8±1.3 | 0.0011 |
| Apelin, ng/mL | 0.27±0.13 | 0.32±0.17 | 0.56±0.17 | <0.0011 |
| SBP, mm Hg | 154±7 | 154±10 | 118±7 | <0.0011 |
| DBP, mm Hg | 92±6 | 95±9 | 78±4 | <0.0011 |
Values are expressed as mean±standard deviation. BMI - body mass index; BSA - body surface area; DBP - diastolic blood pressure; HDL - high-density lipoprotein; LDL - low-density lipoprotein; SBP - systolic blood pressure.
1
- Significant difference between control-amlodipine and control-telmisartan groups